The global alliance of Tilray and Novartis – revolutionising medicinal cannabis
An evolution of the existing alliance between Tilray and Novartis Group is set to increase availability of high-quality medicinal cannabis across the world.
Tilray Canada...
Universal meningitis vaccination is not cost-effective for all
According to Johns Hopkins Medicine, providing universal meningitis vaccination against infection may be too costly to justify cases it would prevent.
Meningitis vaccination is highly...
Motor neuron disease symptoms may be relieved by cannabis sativa plant
An oral spray containing two compounds derived from the cannabis sativa plant reduces spasticity in patients experiencing motor neuron disease symptoms.
Researchers from San Raffaele...
We need to focus more on antidepressant withdrawal relief
Researchers analyse data that can guide antidepressant discontinuation and enable an individual to experience some form of antidepressant withdrawal relief.
There has been a significant...
Inaccuracy in electronic prescribing is warned
Researchers caution warning when using electronic prescribing, as errors are likely to occur in medical record systems.
Electronic prescribing is becoming increasingly common across the...
Opioid-related social isolation could be solved by activating parts of the brain
Opioid-related social isolation is one of the most challenging aspects of the US opioid crisis, however researchers may have cracked the code to help...
EU drug packaging deadline may be missed in event of a no-deal Brexit
Many EU and US pharma companies are unaware that if a no-deal Brexit is reached, they will need to meet a crucial EU drug...
Can a biosynthetic pathway be a new route to antibiotic use?
Scientists have discovered a new route to antibiotic use, exploiting a chemical process and gene editing, also known as a biosynthetic pathway.
Researchers from The...
Concomitant use of benzodiazepine drugs common amongst AD patients
The most commonly concomitant use amongst AD patients was benzodiazepine drugs and a weak opioid – where one in five people with Alzheimer’s disease...
Levels of opioid misuse may be dependent on sexual orientation
According to NYU School of Medicine, men and women identifying as lesbian, gay, or bisexual are at a higher risk of opioid misuse compared...
Medical benefits of cannabis may be less effective than the liverwort plant
For the first time researchers have found that the substance found in the liverwort plant could have the medical benefits of cannabis, and perhaps...
5th Precision Medicine and Biomarkers Leaders Summit: Europe
Health Europa listened to InnVentis CEO Thomas Wilckens discuss some of the diagnostic and data challenges involved in precision medicine.
The 5th Precision Medicine and...
Michael Lisanti and antibiotics: the next cancer revolution
Speaking to Health Europa, Professor Michael Lisanti, MD-PhD, FRSA discusses the potential role of antibiotics in preventing the recurrence of cancer.
How would you cure...
From highly priced medicines to Medicines That Matter
Highly priced medicines represent a significant public health challenge. Global health advocate Ella Weggen shares how Wemos is responding through its dedicated project Medicines...
BioBlocks, Inc.: Transforming the process of lead discovery
BioBlocks CEO Dr Peter Pallai discusses how BioBlocks is making drug discovery more straightforward, faster and more economical using data-driven approaches.
BioBlocks is a medicinal...
Open Targets – transforming drug discovery
Health Europa talks with Open Targets who discuss how the platform works to systematically identify and prioritise drug discovery to develop safe and effective...
Cocaine contaminant, levamisole, may cause brain damage
Individuals who regularly take the cocaine contaminant, levamisole, demonstrate impaired cognitive performance & a thinned prefrontal cortex.
Recent findings from the University of Zurich, Switzerland, indicate...
Prudenta: an electronic solution for local literature monitoring in pharmacovigilance
Dr Polina Dombure, the managing director of Inpharmatis, introduces Prudenta, an innovative pharmacovigilance solution set to transform local literature monitoring.
The costly, time-consuming and error-prone...
Assessing the environmental risk of pharmaceuticals
AstraZeneca’s Jason Snape, outlined his company’s approach to the environmental risk assessment of human medicinal products and what more needs to be in place...
Challenges and opportunities in cancer drug development
Managing director Professor Heinz Zwierzina of the Cancer Drug Development Forum talks Health Europa through the challenges in the search for new cancer drugs.
The...
